Analyzing SCHW – Will It Reach the Moon?

After this morning's 6.5% surge to $72.24 per share, Charles Schwab might just keep moving past its target price of $72.67. With an average analyst rating of buy, and target prices from $60.0 to $88.0, the stock's next move is anyone's guess.

The stock has a very low short interest at 1.1%, and a short ratio of 2.27. The company's insiders own 6.27% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 80.7% of Charles Schwab's shares being owned by this investor type.

Institutions Invested in Charles Schwab

Date Reported Holder Percentage Shares Value
2024-06-30 Toronto Dominion Bank 13% 225,962,971 $16,323,564,542
2024-06-30 Vanguard Group Inc 7% 122,207,640 $8,828,279,652
2024-06-30 Blackrock Inc. 6% 101,023,390 $7,297,929,477
2024-06-30 Dodge & Cox Inc 5% 85,787,053 $6,197,256,525
2024-06-30 Price (T.Rowe) Associates Inc 5% 85,194,207 $6,154,429,331
2024-06-30 State Street Corporation 3% 61,661,498 $4,454,426,483
2024-06-30 JP Morgan Chase & Company 2% 43,992,195 $3,177,996,072
2024-06-30 Geode Capital Management, LLC 2% 29,696,137 $2,145,248,873
2024-06-30 Massachusetts Financial Services Co. 2% 26,967,993 $1,948,167,756
2024-06-30 Morgan Stanley 1% 23,181,092 $1,674,602,036

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Charles Schwab.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS